| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | President and CEO, Director | $485K | Sep 25, 2025 | ||
| VIVE | VIVEVE MEDICAL, INC. | Director | Jan 3, 2023 | |||
| VYNE | VYNE Therapeutics Inc. | Director | Dec 12, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|